cH 30 ASTHMA EXAM WITH |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
CORRECT ANSWERS |||\\\
Prior to developing a plan for the treatment of asthma, the patient's asthma should be
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
classified according to the NHLBI Expert Panel 3 guidelines. In adults mild-persistent asthma is
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
classified as asthma symptoms that occur: |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
|||\\\
1. Daily |||\\\ |||\\\
2. Daily and limit physical activity
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
3. Less than twice a week
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
4. More than twice a week and less than once a day - correct answer✔✔4
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
In children age 5 to 11 years mild-persistent asthma is diagnosed when asthma symptoms
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
occur:
|||\\\
1. At nighttime one to two times a month
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
2. At nighttime three to four times a month
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
3. Less than twice a week
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
4. Daily - correct answer✔✔2
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\
One goal of asthma therapy outlined by the NHLBI Expert Panel 3 guidelines is:
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
|||\\\
1. Ability to use albuterol daily to control symptoms
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
2. Minimize exacerbations to once a month
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
3. Keep nighttime symptoms at a maximum of twice a week
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
4. Require infrequent use of beta 2 agonists (albuterol) for relief of symptoms - correct
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
answer✔✔4
, A stepwise approach to the pharmacologic management of asthma:
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
|||\\\
1. Begins with determining the severity of asthma and assessing asthma control
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
2. Is used when asthma is severe and requires daily steroids
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
3. Allows for each provider to determine their personal approach to the care of asthmatic
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
patients |||\\\
4. Provides a framework for the management of severe asthmatics, but is not as helpful when
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
patients have intermittent asthma - correct answer✔✔1
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
Treatment for mild intermittent asthma is: |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
|||\\\
1. Daily inhaled medium-dose corticosteroids
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\
2. Short-acting beta-2-agonists (albuterol) as needed
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
3. Long-acting beta-2-agonists every morning as a preventative
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
4. Montelukast (Singulair) daily - correct answer✔✔2
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
The first-line therapy for mild-persistent asthma is:
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
|||\\\
1. High-dose montelukast
|||\\\ |||\\\ |||\\\
2. Theophylline
|||\\\ |||\\\
3. Low-dose inhaled corticosteroids
|||\\\ |||\\\ |||\\\ |||\\\
4. Long-acting beta-2-agonists - correct answer✔✔3
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
Monitoring a patient with persistent asthma includes: |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
|||\\\
1. Monitoring how frequently the patient has an upper respiratory infection (URI) during
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
treatment |||\\\
2. Monthly in-office spirometry testing
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\
3. Determining if the patient has increased use of his or her long-acting beta-2-agonist due to
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
exacerbations |||\\\
CORRECT ANSWERS |||\\\
Prior to developing a plan for the treatment of asthma, the patient's asthma should be
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
classified according to the NHLBI Expert Panel 3 guidelines. In adults mild-persistent asthma is
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
classified as asthma symptoms that occur: |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
|||\\\
1. Daily |||\\\ |||\\\
2. Daily and limit physical activity
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
3. Less than twice a week
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
4. More than twice a week and less than once a day - correct answer✔✔4
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
In children age 5 to 11 years mild-persistent asthma is diagnosed when asthma symptoms
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
occur:
|||\\\
1. At nighttime one to two times a month
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
2. At nighttime three to four times a month
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
3. Less than twice a week
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
4. Daily - correct answer✔✔2
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\
One goal of asthma therapy outlined by the NHLBI Expert Panel 3 guidelines is:
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
|||\\\
1. Ability to use albuterol daily to control symptoms
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
2. Minimize exacerbations to once a month
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
3. Keep nighttime symptoms at a maximum of twice a week
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
4. Require infrequent use of beta 2 agonists (albuterol) for relief of symptoms - correct
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
answer✔✔4
, A stepwise approach to the pharmacologic management of asthma:
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
|||\\\
1. Begins with determining the severity of asthma and assessing asthma control
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
2. Is used when asthma is severe and requires daily steroids
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
3. Allows for each provider to determine their personal approach to the care of asthmatic
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
patients |||\\\
4. Provides a framework for the management of severe asthmatics, but is not as helpful when
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
patients have intermittent asthma - correct answer✔✔1
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
Treatment for mild intermittent asthma is: |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
|||\\\
1. Daily inhaled medium-dose corticosteroids
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\
2. Short-acting beta-2-agonists (albuterol) as needed
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
3. Long-acting beta-2-agonists every morning as a preventative
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
4. Montelukast (Singulair) daily - correct answer✔✔2
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
The first-line therapy for mild-persistent asthma is:
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
|||\\\
1. High-dose montelukast
|||\\\ |||\\\ |||\\\
2. Theophylline
|||\\\ |||\\\
3. Low-dose inhaled corticosteroids
|||\\\ |||\\\ |||\\\ |||\\\
4. Long-acting beta-2-agonists - correct answer✔✔3
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
Monitoring a patient with persistent asthma includes: |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
|||\\\
1. Monitoring how frequently the patient has an upper respiratory infection (URI) during
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
treatment |||\\\
2. Monthly in-office spirometry testing
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\
3. Determining if the patient has increased use of his or her long-acting beta-2-agonist due to
|||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\ |||\\\
exacerbations |||\\\
